Hepion terminates merger with Pharma Two B; special meeting cancelled

Hepion Pharmaceuticals, Inc.

Merger Agreement with Pharma Two B Ltd. terminated mutually on Dec 10, 2024.
No termination fee payable by either party.
Special stockholders meeting scheduled for Dec 12, 2024 cancelled; proposals withdrawn.
Nasdaq would not exclude historical losses from burn-rate calculation, leading to termination.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.